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Abstract
Introduction Our purpose was to determine whether perfu-
sion MR imaging can be used to differentiate benign and
malignant meningiomas on the basis of the differences in
perfusion of tumor parenchyma and/or peritumoral edema.
Methods A total of 33 patients with preoperative meningi-
omas (25 benign and 8 malignant) underwent conventional
and dynamic susceptibility contrast perfusion MR imaging.
Maximal relative cerebral blood volume (rCBV) and the
corresponding relative mean time to enhance (rMTE)
(relative to the contralateral normal white matter) in both
tumor parenchyma and peritumoral edema were measured.
The independent samples t-test was used to determine
whether there was a statistically significant difference in the
mean rCBV and rMTE ratios between benign and malig-
nant meningiomas.
Results The mean maximal rCBV values of benign and
malignant meningiomas were 7.16±4.08 (mean±SD) and
5.89±3.86, respectively, in the parenchyma, and 1.05±0.96
and 3.82±1.39, respectively, in the peritumoral edema. The
mean rMTE values were 1.16±0.24 and 1.30±0.32, respec-
tively, in the parenchyma, and 0.91±0.25 and 1.24±0.35,
respectively, in the peritumoral edema. The differences in
rCBV and rMTE values between benign and malignant
meningiomas were not statistically significant (P>0.05) in
the parenchyma, but both were statistically significant
(P<0.05) in the peritumoral edema.
Conclusion Perfusion MR imaging can provide useful
information on meningioma vascularity which is not avail-
able from conventional MRI. Measurement of maximal
rCBV and corresponding rMTE values in the peritumoral
edema is useful in the preoperative differentiation between
benign and malignant meningiomas.
Keywords Meningioma.Cerebralneoplasm.
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Brain
Introduction
Meningiomas are the most common primary nonglial
neoplasm, representing 15–20% of all primary brain tumors
[1]. According to the classification of nervous system tumors
of the World Health Organization (WHO) in 2000, there are
three types of meningiomas based on malignant behavior:
common benign (grade I), atypical (grade II), and malignant
(grades III and IV). Grade I meningiomas have a recurrence
rate of 6.9%, and despite invasion of the adjacent bony
structures, do not invade the brain parenchyma. Grade II
meningiomas have a recurrence rate of 34.6%, and show
frequent mitosis and an increased nuclear-cytoplasmic ratio.
Malignant meningiomas (grades III and IV) have a recur-
rence rate of 72.7%, and show an even greater mitosis rate as
well as necrosis and invasion of brain parenchyma [2].
Differentiating between malignant and benign meningio-
mas before surgery is important for both treatment planning
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some identifiable imaging features on conventional MR
images, no special feature has been found to be reliable in
predicting tumor grade. Sometimes, the aggressiveness of the
tumor cannot be accurately characterized even on the basis of
histopathological findings [3, 4]. Perfusion MR imaging
reflects the characteristics of the regional blood supply, an
important biological marker of tumor grade and prognosis.
The purpose of this study was to evaluate the possible role
of dynamic susceptibility contrast (DSC) perfusion MR
imaging in grading of meningiomas. For the first time, the
maximal relative cerebral blood volume (rCBV) (relative to
the contralateral normal white matter) and corresponding
relative mean time to enhance (rMTE) were measured in the
tumor parenchyma and also in the peritumoral edema.
Materials and methods
Patients
Between January 2002 and December 2006, 33 patients (15
male, 18 female) with supratentorial meningiomas and
peritumoral edema (25 benign and 8 malignant) were
enrolled in this study. Their average age was 46 years,
with a range of 17–63 years. All patients underwent gross
total or subtotal resection of the tumor within 20 days of
conventional and DSC perfusion MR imaging. All results
were histopathologically confirmed.
MRI protocol
MR examinations were performed on a 1.5-Tclinical system
(Signa; GE Medical Systems; Milwaukee, WI). Sagittal and
axial T1-weighted spin-echo (TR/TE 440/14 ms, matrix
256×256, section thickness 8 mm, field of view 22 cm),
axial fluid attenuated inversion recovery (FLAIR) sequences
(TR/TE 8002/126 ms) were performed before enhancement.
Then 0.1 mmol/kg Gd-DTPA (Omniscan, GE Medical
Systems) was administered intravenously with a power
injector (Medrad, Indianola, PA) at a rate of 4 ml/s, followed
by a 20-ml saline flush at the same rate. T2*-weighted
dynamic susceptibility contrast-enhanced perfusion MR
imaging was performed 5 s after the beginning of the
injection using a gradient-echo echo-planar sequence with
the following parameters: TR/TE 1800/40 ms, number of
excitations 1, flip angle 60°, bandwidth 62.75, matrix 128×
128, number of sections 10, section thickness 8 mm without
spacing, 8–10 slices per acquisition, field of view 22 cm, and
acquisition time 1 min 38 s. A series of 50 dynamic
acquisitions were obtained for each section during the bolus
injection of Gd-DTPA. Then, postcontrast sagittal and axial
spin-echo T1-weighted sequences were performed using the
same section positions and parameters as the corresponding
precontrast sequences.
Data analysis
The images were analyzed using Functool software (ADW
4.0, GE Medical Systems, Milwaukee, WI). A dynamic
perfusion technique with contrast medium demonstrates
cerebral hemodynamics by analyzing changes in the signal
intensities after administration of contrast material. During
the first phase of passage of the contrast agent bolus, both
T2* relaxation time and its equivalent T2* signal intensity
decrease. The change in relaxation rate (ΔR2*) can be
calculated on the basis of signal intensity by means of the
followingequation:ΔR2*= −ln[S(t)/S0]echo time, where S(t)
and S0 are the signal intensities at time t and baseline. The
recirculation and T1 shortening effects caused by contrast
agent leakage can be reduced by fitting a gamma-variate
function to the measured ΔR2* curve. The area under the
corrected contrast agent concentration–time curve is propor-
tional to the CBV and does not yield an absolute value. It is
necessary, therefore, to express CBV relative to that of a
standard reference area, usually the contralateral white matter.
We refer to this as relative CBV (rCBV). Since we cannot
determine the arterial input function using this software, the
mean time to enhance (MTE) in this study is related to the
time to peak and to the width of the peak of the time signal
curve; MTE is computed and displayed only for the images
between the last preenhancement image and the first
postenhancement image, equivalent to the bolus arrival time.
The steps to create perfusion maps have been described
in detail previously by Knopp et al. [5]. The source images
are first inspected for overall image quality and motion
artifact. A single region of interest (ROI) is placed over the
contralateral unaffected centrum semiovale white matter,
and rCBV maps are generated to serve as road maps. CBV
maps can then be calculated on a pixel-by-pixel basis and
displayed as a gray-scale image. However, small but
important variations in CBV are not always apparent from
these maps. An alternative is to use a color overlay
displayed on the raw image, in which the abnormal CBV
values are often more apparent. A threshold for the color
overlay at a CBV the same as that of the unaffected white
matter was used in this study. In some peritumoral edema
regions which had lower CBV than normal, the white
matter showed as black in color and the maximal rCBV of
these regions were determined mainly from the degree of
signal intensity change (peak depth of the time–signal
curve) of the respective ROIs. The degree of signal
intensity change correlates well with rCBV, so the region
with the highest rCBV is easily identified. Furthermore, in
lesions that are located close to major vascular structures,
careful inspection of the signal intensity–time curve clearly
526 Neuroradiology (2008) 50:525–530indicates vessels that produce very large signal intensity
changes. At least three circular ROIs, including at least 20
pixels each, were placed on the highest color levels of the
solid part of the parenchyma and peritumoral edema of a
tumor, and the maximal values were recorded. Peritumoral
edema in this study was defined as areas of high signal on
FLAIR images and within 1 cm of the outer enhancing
tumor margin on postcontrast T1-weighted images. The
same ROIs were also applied to MTE maps. For quantita-
tive analysis, normal white matter within the contralateral
hemisphere was used as the internal reference standard, and
rCBV and rMTE values were calculated by dividing the
maximal CBV and MTE of a tumor by that of the
contralateral normal white matter.
Statistical analysis was performed with commercially
available software (SPSS, version 14.0 for Windows; SPSS,
Chicago, IL). The means of the maximum rCBV and the
corresponding rMTE values of benign and malignant menin-
giomas were expressed as means±standard error of the mean.
The differences between the means of benign and malignant
meningiomas were compared using an independent-samples
t-test. P values less than 0.05 indicated a statistically
significant difference.
Results
All tumors in this study were correctly diagnosed as
meningiomas by evaluating the pre- and postenhancement
images from conventional MRI sequences. No diagnosis of
tumor malignancy or grading could be made on the basis of
the conventional MR images. The parenchyma of more than
half of the benign meningiomas (n=16, 64%) was isointense
on T1-weighted MR images, and showed homogeneous
enhancement after contrast medium administration with low
signal of abnormal, tortuous tumor vessels in or surrounding
the tumors. Peritumoral edema was most clearly seen on
FLAIR images.
On the rCBV color maps, the parenchyma of all
meningiomas showed uneven but higher blood volume
than the surrounding tissues, and was represented as “hot”
colors (red, orange and yellow). In all meningiomas, the
Fig. 1 Histopathologically confirmed benign meningioma (WHO grade
I). a–c MR images. T1-weighted (a), FLAIR (b) and contrast-enhanced
T1-weighted (c) images show an inhomogeneous mass lesion on the
right convexity with little peritumoral edema and heterogeneous
enhancement. d rCBV map. The “hot” colors (red) of ROI 1 in the
tumor parenchyma indicates a higher rCBV than the normal white matter
(ROI 3, blue); the black color of ROI 2 in peritumoral edema indicates a
lower rCBV than the normal white matter. The reference color scale is on
the right side of the map. e rMTE map. The colors of the tumor
parenchyma and peritumoral edema are similar to that of normal brain
tissues; no clear interface can be seen
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tumor parenchyma. Some marginal parts of malignant
meningiomas were blurred on the rCBV maps and showed
no clear interface with the surrounding brain tissues. The
areas of maximal blood volume in the peritumoral edema of
malignant meningiomas were represented as slightly “hot-
ter” or the same colors (green and blue) compared to
normal white matter (blue) on the rCBV color maps. While
both the tumor parenchyma and peritumoral edema of
malignant meningiomas were represented as slightly “hot-
ter” colors than areas of normal brain tissues on rMTE color
maps, the tumor parenchyma and peritumoral edema of
benign meningiomas showed similar colors to normal brain
tissue on rMTE color maps. The interfaces between tumor
parenchyma and peritumoral edema of benign meningiomas
were blurred on rMTE color maps (Figs. 1 and 2).
The mean maximal rCBV values and corresponding rMTE
values of tumor parenchyma and peritumoral edema are shown
in Table 1 with the statistical results derived from comparing
the mean values between benign and malignant meningiomas.
Fig. 2 Histopathologically confirmed malignant meningioma (WHO
grade III). a–c MR images. T1-weighted (a), FLAIR (b) and contrast-
enhanced T1-weighted (c) images show a mass with nearly isointense
parenchyma accompanied by widespread peritumoral brain edema and
strong homogeneous enhancement. d rCBV map. The red color of
ROI 1 in the tumor parenchyma indicates a higher rCBV than the
surrounding brain tissues; the green and blue colors of ROI 2 in the
peritumoral edema are also “hotter” than ROI 3 (dark) in the normal
white matter. The reference color scale is on the right side of the map.
e MTE map. Most of the tumor parenchyma shows slightly “hotter”
colors than the normal brain tissue, reflecting a prolonged rMTE
Table 1 Comparison of rCBV and rMTE values of benign and malignant meningiomas. The values presented are relative values in comparison
with the contralateral white matter (assumed to have a value 1.00)
Meningioma rCBV rMTE
Parenchyma Peritumoral edema Parenchyma Peritumoral edema
Benign (n=25) 7.16±4.08 1.05±3.86 1.16±0.24 0.91±0.25
Malignant (n=8) 5.89±3.86 3.28±1.39 1.30±0.32 1.24±0.35
P value
a 0.078 0.002 0.278 0.032
aIndependent samples t-test. P values <0.05 indicate a statistically significant difference
528 Neuroradiology (2008) 50:525–530Discussion
The distinction between benign and malignant meningio-
mas is clinically relevant because of their different
recurrence rate [2]. Differentiating between benign and
malignant meningioma before surgery could be helpful in
the planning of surgical resection and adjunctive radiation
therapy. The characteristics of meningiomas demonstrated
on images derived from conventional MR sequences cannot
always be used to reliably differentiate between benign and
malignant tumors. In our study of 33 patients, all tumors
were diagnosed correctly as meningiomas using conven-
tional MR sequences. Nevertheless, distinguishing between
benign and malignant meningiomas can be difficult if not
impossible with conventional MR imaging sequences.
Determining CBV from DSC perfusion MR imaging
data has previously been shown to be useful in differenti-
ating gliomas of different grades [5, 6]. The most widely
used DSC perfusion MR imaging technique is based on the
intravascular indicator dilution theory of Zierler [7] which
states that, in the absence of recirculation and contrast
material leakage, CBV is proportional to the area under the
contrast agent concentration–time curve and does not yield
an absolute measurement. For the latter it is necessary to
express CBV relative to that of a standard reference area,
usually the contralateral white matter. Nevertheless, the
above-mentioned assumptions are violated in meningiomas,
because they lack a true blood–brain barrier. Several
methods for correcting for the under- or overestimation of
rCBV measurements from DSC imaging in regions of
microvascular leakage and for compensating for the T1
shortening effects caused by contrast leakage into the
tumoral interstitial space have been studied, but none is
considered a standard reference method [8–10].
Previous attempts to assess the grade of meningiomas
using DSC perfusion MR with determination of the rCBV
of the tumor parenchyma have not been successful. Zhu
et al. [11] found no correlation between rCBV and tumor
grade in 2 malignant and 12 benign meningiomas. In
another study Yang et al. [8] found no significant difference
between the rCBV values of 7 atypical and 15 benign
meningiomas. These findings are consistent with our
results. In our study, the mean rCBV value derived from
the maximal blood volume regions in the parenchyma of
benign meningiomas was higher than that of malignant
meningiomas, but the difference between the two groups
showed no statistical significance. The means of the MTE
values in the parenchyma of both benign and malignant
meningiomas were longer than those of normal brain tissue
but there was no statistically significant difference between
benign and malignant meningiomas. These findings could
be attributed to the immature and tortuous tumor vessels
which could result in an increased leakage of contrast agent
from vessels into the extravascular space and deceleration
of blood flow in the tumor parenchyma.
The notable and original results of this study were that
the mean maximal rCBV and corresponding rMTE values
of peritumoral edema of malignant meningiomas were
greater than those of benign meningiomas and significant
differences were found between the two groups (P<0.05).
The increase in rCBV in the peritumoral edema of
malignant meningiomas might be attributed to tumor
invasion and angiogenesis in the adjacent brain tissue
[12]. Previous studies focusing on the pathological and
molecular characteristics of meningiomas have shown that
FLT1- and VEGF-positive cells are increased in the
endothelium of intratumoral vessels and are associated with
microvascular proliferations in peritumoral brain tissue of
anaplastic meningiomas [13]. We consider that the different
transit times between benign and malignant meningiomas
in our study group was due to a multifactorial effect
including tumor size, vascular compression, capillary
permeability and vessel tortuosity, which have been
evaluated in other studies [14, 15]. To our knowledge, no
previous studies have examined the microcirculation in the
peritumoral edema of meningiomas by means of perfusion-
weighted MR imaging. In this study, the number of patients
was limited and physiopathological details of the areas of
peritumoral edema were not available for comparison with
the perfusion MR findings in order to prove the assump-
tions made. Studies with larger sample sizes and more
detailed evaluation of the physiopathology of the peritu-
moral edema of meningiomas of different grade are needed.
Conclusion
DSC perfusion MR imaging can provide critical informa-
tion on the vascularity of meningiomas which is not
available with conventional MR imaging. Determination
of maximal rCBV and corresponding rMTE values in the
peritumoral edema is useful in the preoperative differenti-
ation between benign and malignant meningiomas.
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